Orchid Pharma consolidated Q2 FY24 net profit up at Rs. 19.80 Cr
Orchid Pharma reported total income of Rs. 207.11 crores during the period ended September 30, 2023
Orchid Pharma reported total income of Rs. 207.11 crores during the period ended September 30, 2023
Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023
The company has reported total income of Rs.129.14 crores during the period ended December 31, 2022 as compared to Rs.157.54 crores during the period ended December 31, 2021.
Revenue from operations during the quarter was up by 6.7 per cent to Rs 6,407.10 crore against Rs 6,002.2 in the same period last fiscal.
The company has reported total income of Rs. 79.33 crores during the period ended December 31, 2022
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
The company has reported total income of Rs. 61.64 crores during the period ended September 30, 2022.
Subscribe To Our Newsletter & Stay Updated